←Back to Expert Scholars
Translational Medicine / 转化医学Biliary Tract Cancer Combination Therapy
Robin Kate Kelley
MD
🏢University of California San Francisco🌐USA
Professor of Clinical Medicine
52
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Dr. Robin Kate Kelley leads hepatobiliary clinical research at UCSF. She contributed to the HIMALAYA trial and other pivotal hepatocellular and biliary tract cancer studies. Her work integrates immunotherapy combinations into advanced hepatobiliary disease management.
Share:
🧪Research Fields 研究领域
hepatocellular carcinoma
cholangiocarcinoma
immunotherapy
combination therapy
HIMALAYA
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Robin Kate Kelley 的研究动态
Follow Robin Kate Kelley's research updates
留下邮箱，当我们发布与 Robin Kate Kelley（University of California San Francisco）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment